Kennett Square, Pennsylvania — Even as occupancy falls and uncertainty swirls around its pending sale, Genesis HealthCare is pushing for nearly $10 million in executive and employee performance incentives — and it needs a federal bankruptcy judge to sign off before it can pay a dime.
The once-dominant skilled nursing operator filed a request last week with U.S. Bankruptcy Judge Stacey Jernigan, asking the court to approve a three-part incentive and retention plan for more than 350 employees — from frontline managers to senior executives. The company’s attorneys argued the payments are necessary to prevent a wave of departures before the sale closes.
“Although there is now a light at the end of the tunnel, the Debtors face challenges retaining key members of their management and executive team,” lawyers for Genesis wrote in the court filing. The company has already seen “significant recent resignations of key regional and field-level personnel,” they noted, driven by the extended uncertainty of a bankruptcy process that’s stretched well beyond its original timeline.
Three-Part Plan, Three Separate Asks
The request breaks down into three categories. First, Genesis wants to release roughly $6.6 million to 358 non-insider employees who were previously approved for bonuses but have been waiting — some for months longer than expected — because the sale keeps getting delayed. Those bonuses were also bumped up by about 33% to compensate for the extended wait.
Second, an additional $1.6 million would go to 12 senior executives who hit their 2025 performance targets but can’t receive anything without a fresh court order. And third, a separate $1.5 million retention pool would cover 10 senior managers — including roles like controller and chief operating officer — some of whom are legally classified as insiders under bankruptcy law, making court sign-off especially critical.
All payments are performance-based and subject to clawback if a recipient voluntarily leaves or is terminated for cause before the sale closes.
Occupancy Is Slipping as the Sale Drags On
Genesis’ attorneys didn’t shy away from flagging operational headwinds in the filing. Occupancy dropped 2.6% from 2024 to 2025, and lawyers warned that “growing resident uncertainty surrounding the Sale Transaction” is making it even harder to keep beds filled. Lower occupancy means lower revenue — which means less money available to satisfy creditors once the deal closes.
Genesis is set to be sold to West State Street Holdings for $996 million. The deal was originally expected to close in early 2026 but slipped after the bankruptcy judge tossed the first auction’s results over transparency concerns. A second auction was approved in mid-January, with closing now penciled in for late June. This latest chapter follows the company’s earlier move to secure an $80 million financing lifeline to stabilize operations through the ownership transition.
Creditors Have Until Late March to Object
Parties in the case had 24 days from the February 28 filing to formally object — putting the objection deadline in late March. The creditor committee’s reaction will be worth watching. Any bonus payments come directly out of the pot that’s supposed to repay debts after the sale, so there’s real tension between retaining staff and making creditors whole.
A Genesis spokeswoman said incentive and retention programs are “important tools” that’re common in bankruptcy proceedings, and that the company’s leaders have “continued to operate our centers without compromising care.” She said the request was made “transparently and respectfully.”
Whether Judge Jernigan agrees — and whether creditors push back — will shape how the final stretch of one of long-term care’s most closely-watched bankruptcies plays out.
